PDCD1 and neoplasm: This has been attributed to a number of factors: a low rate of tumor mutational burden, generally inadequate T cell infiltration, and relatively low expression of immune regulation markers, including programmed cell death 1 (PDCD1) and its ligands (PD-L1 and PD-L2) (18, 25, 28, 29).